SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I

PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I

Retrieved on: 
화요일, 2월 15, 2022
Health, Technology, Other Technology, Other Health, General Health, Clinical Trials, Biotechnology, Adoption, LSE, Prospectus, XV, Private Securities Litigation Reform Act, Therapy, Technology, Suite, U.S. Securities and Exchange Commission, Government budget balance, Acquisition, U.S. FDA, Entrepreneurship, COVID-19, PALO, Mergers and acquisitions, Company, PRTC, Tripura Merger Agreement, SEC, Xi, Registration statement, Securities Act of 1933, Vii, SCS, Twitter, Degenerative disease, Sale, Research, 100,000, Industry, Connection, Social capital, ALL, Risk, Brain, Capitalism, Nasdaq, THE, Register, PureTech Health, Name, Cancer, Communication, Medicine, Form, Business architecture, Forward-looking statement, Annual report, Environment, Proxy, Biology, FDA, Axis, Failure, BIG, Online gambling, Audit, Security (finance), Property management, Risk management, Yolo Akili, Akili, Social Capital, Social Capital Suvretta Holdings Corp I, PureTech Health, AKILI, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I, PURETECH HEALTH

The full text of the announcement from Akili is as follows:

Key Points: 
  • The full text of the announcement from Akili is as follows:
    Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp.
  • and PALO ALTO, Calif. February 14, 2022 Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, announced that Social Capital Suvretta Holdings Corp.
  • I (SCS) (Nasdaq: DNAA) has filed with the U.S. Securities and Exchange Commission (SEC) a registration statement on Form S-4 (the Registration Statement), which contains a preliminary proxy statement/prospectus, in connection with the previously announced proposed business combination with Akili.
  • While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Akili and the proposed business combination with SCS.

Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I

Retrieved on: 
월요일, 2월 14, 2022
Health, Technology, Mobile, Wireless, Clinical Trials, General Health, Biotechnology, Social capital, Mergers and acquisitions, Adoption, Form, Prospectus, ALL, Risk, Registration statement, Tripura Merger Agreement, Brain, SEC, Forward-looking statement, Xi, XV, Capitalism, Nasdaq, THE, Register, Technology, Proxy, Suite, Vii, U.S. Securities and Exchange Commission, Name, SCS, Securities Act of 1933, Government budget balance, Sale, Communication, Acquisition, Failure, Industry, Entrepreneurship, Research, 100,000, COVID-19, Medicine, Online gambling, Property management, Yolo Akili, Akili, Social Capital, Social Capital Suvretta Holdings Corp I, AKILI, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I

Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, announced that Social Capital Suvretta Holdings Corp.

Key Points: 
  • Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, announced that Social Capital Suvretta Holdings Corp.
  • I (SCS) (Nasdaq: DNAA) has filed with the U.S. Securities and Exchange Commission (SEC) a registration statement on Form S-4 (the Registration Statement), which contains a preliminary proxy statement/prospectus, in connection with the previously announced proposed business combination with Akili.
  • While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Akili and the proposed business combination with SCS.
  • Neither Akili nor SCS gives any assurance that either Akili or SCS, or the combined company, will achieve its expectations.

Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Retrieved on: 
수요일, 1월 26, 2022
Technology, Mobile, Wireless, Venture Capital, Other Technology, Professional Services, Biotechnology, Other Health, Health, Pharmaceutical, Akili, Social Capital, Social Capital Suvretta Holdings Corp I, AKILI, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I

Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Suvretta Holdings Corp.

Key Points: 
  • Akili Interactive (Akili or the Company), a leading digital medicine company developing cognitive treatments through game-changing technologies, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Suvretta Holdings Corp.
  • This core platform has the potential to be applied across a diverse set of indications within psychiatry and neurology.
  • With its first-ever, clinically validated digital therapeutic (EndeavorRx), Akili has the unique opportunity to change how we treat pediatric ADHD.
  • Neither Akili nor SCS gives any assurance that either Akili or SCS, or the combined company, will achieve its expectations.

PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Retrieved on: 
수요일, 1월 26, 2022
Health, FDA, Other Health, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Akili, Social Capital, Social Capital Suvretta Holdings Corp I, PureTech Health, AKILI, SOCIAL CAPITAL, SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I, PURETECH HEALTH

The full text of the announcement from Akili is as follows:

Key Points: 
  • The full text of the announcement from Akili is as follows:
    Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp.
  • Specifically, current treatment options are designed to focus on symptoms and coping strategies instead of directly targeting cognitive functioning.
  • These therapeutic shortfalls are especially concerning for younger populations who are potentially facing a lifetime of managing these conditions.
  • With its first-ever, clinically validated digital therapeutic (EndeavorRx), Akili has the unique opportunity to change how we treat pediatric ADHD.